Last: | $48.54 |
---|---|
Change Percent: | 1.49% |
Open: | $48.85 |
Close: | $48.54 |
High: | $48.85 |
Low: | $48.45 |
Volume: | 2,646,375 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$48.54 | $48.85 | $48.54 | $48.85 | $48.45 | 2,646,375 | 07-02-2024 |
$49.59 | $49.38 | $49.59 | $49.67 | $49.24 | 3,045,372 | 07-01-2024 |
$48.52 | $48.12 | $48.52 | $48.96 | $48.045 | 3,048,949 | 06-28-2024 |
$48.08 | $48.4 | $48.08 | $48.42 | $47.85 | 1,097,152 | 06-27-2024 |
$48.33 | $48.22 | $48.33 | $48.9 | $48.19 | 4,095,634 | 06-26-2024 |
$50.11 | $48.57 | $50.11 | $50.27 | $48.48 | 3,156,276 | 06-25-2024 |
$48.97 | $48.37 | $48.97 | $49.19 | $48.37 | 5,560,248 | 06-24-2024 |
$47.21 | $47 | $47.21 | $47.28 | $46.51 | 4,986,733 | 06-21-2024 |
$46.85 | $46.9 | $46.85 | $47.22 | $46.81 | 2,627,563 | 06-20-2024 |
$47.22 | $47.58 | $47.22 | $47.59 | $47.16 | 2,947,770 | 06-19-2024 |
$47.22 | $47.58 | $47.22 | $47.59 | $47.16 | 2,947,770 | 06-18-2024 |
$47.29 | $46.69 | $47.29 | $47.31 | $46.3701 | 2,578,139 | 06-17-2024 |
$46.25 | $46.8 | $46.25 | $46.85 | $45.9 | 3,797,354 | 06-14-2024 |
$47.53 | $47.44 | $47.53 | $47.595 | $47.0834 | 2,244,738 | 06-13-2024 |
$48.44 | $48.48 | $48.44 | $48.94 | $48.16 | 1,966,036 | 06-12-2024 |
$48.51 | $48.15 | $48.51 | $48.6 | $48.02 | 5,399,074 | 06-11-2024 |
$48.86 | $48.24 | $48.86 | $48.86 | $48.11 | 3,570,027 | 06-10-2024 |
$48.98 | $49.26 | $48.98 | $49.42 | $48.94 | 1,284,163 | 06-07-2024 |
$49.51 | $49.09 | $49.51 | $49.6 | $49.03 | 1,065,211 | 06-06-2024 |
$49.13 | $49.63 | $49.13 | $49.77 | $49.07 | 1,956,219 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Compared to their non-orphan counterparts, orphan drugs have consistently outpaced growth and have become a major part of pharma’s mainstream business. The U.S. FDA's orphan drug designation, established under the Orphan Drug Act of 1983, encourages the development of trea...
2024-06-09 09:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...